L & S Advisors Inc Edwards Lifesciences Corp Transaction History

L & S Advisors Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$46.41 - $56.94 $584,023 - $716,532	-12,584 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$45.7 - $58.03 $273,788 - $347,657	-5,991 Reduced 32.25%	12,584 $2.19 Million
Q2 2018 Aug 13, 2018	SELL	$42.45 - $51.3 $277,368 - $335,194	-6,534 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$37.19 - $47.45 $242,999 - $310,038	6,534 New	6,534 $912,000

1,350

457M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of L & S Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on L & S Advisors Inc with notifications on news.